Go Pro

Danaher Corporation Plans Quarterly Dividend of $0.40 (NYSE:DHR)

Danaher logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Danaher declared a quarterly dividend of $0.40 per share, payable October 30 to shareholders of record on September 30. The dividend equates to $1.60 annually and a yield of approximately 0.8%.
  • The dividend appears well covered, with a payout ratio of 18.7%; analysts expect next year’s earnings to support an estimated payout ratio of 17.3%.
  • Danaher’s latest quarterly results exceeded expectations, reporting $1.94 in earnings per share versus the $1.85 consensus and $6.26 billion in revenue, up 5.5% year over year.
  • Five stocks we like better than Danaher.

Danaher Corporation (NYSE:DHR - Get Free Report) announced a quarterly dividend on Tuesday, September 15th. Shareholders of record on Wednesday, September 30th will be given a dividend of 0.40 per share by the conglomerate on Friday, October 30th. This represents a c) dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Wednesday, September 30th.

Danaher has increased its dividend by an average of 0.1%per year over the last three years and has increased its dividend annually for the last 2 consecutive years. Danaher has a dividend payout ratio of 18.7% indicating that its dividend is sufficiently covered by earnings. Analysts expect Danaher to earn $9.26 per share next year, which means the company should continue to be able to cover its $1.60 annual dividend with an expected future payout ratio of 17.3%.

Danaher Stock Performance

Shares of DHR opened at $209.23 on Wednesday. The firm has a market cap of $147.09 billion, a PE ratio of 37.16, a PEG ratio of 2.53 and a beta of 0.78. The stock's fifty day moving average price is $203.15 and its two-hundred day moving average price is $191.90. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. Danaher has a 1 year low of $160.93 and a 1 year high of $242.80.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, topping the consensus estimate of $1.85 by $0.09. The company had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The firm's quarterly revenue was up 5.5% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.77 EPS. On average, equities research analysts forecast that Danaher will post 8.53 EPS for the current year.

Danaher Company Profile

(Get Free Report)

Danaher Corporation NYSE: DHR is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its businesses support pharmaceutical and biotechnology research, biomanufacturing, clinical laboratories and healthcare providers.

The company's portfolio includes bioprocessing technologies, laboratory instruments, consumables, reagents and software. Key businesses include Cytiva, which provides biomanufacturing solutions; Beckman Coulter, which supplies laboratory diagnostics and automation systems; Leica Biosystems, which develops pathology products; and IDT, which provides genomic and nucleic acid products.

Further Reading

Dividend History for Danaher (NYSE:DHR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Danaher Right Now?

Before you consider Danaher, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.

While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines